Acute Effects of Handgrip on Blood Pressure in Hypertensive Adults
Acute Effects of Handgrip on Vascular Function and Ambulatory Blood Pressure in Hypertensive Adults: A Randomized Controlled Trial
1 other identifier
interventional
11
1 country
1
Brief Summary
The effect of handgrip training on blood pressure reduction has been demonstrated in several studies. However, acutely, there is still divergence regarding the effects of isometric handgrip exercise on blood pressure responses, especially when it is performed at different times of the day. It is suggested that the magnitude of blood pressure reduction after a single exercise session is able to predict long-term blood pressure behavior. Thus, understanding the effects of isometric handgrip exercise, performed at different times of the day, on blood pressure in adult hypertensive individuals acutely may help to understand the effects of this type of exercise chronically.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable hypertension
Started Jun 2021
Shorter than P25 for not_applicable hypertension
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
April 14, 2021
CompletedFirst Posted
Study publicly available on registry
April 23, 2021
CompletedStudy Start
First participant enrolled
June 1, 2021
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2021
CompletedSeptember 30, 2021
September 1, 2021
3 months
April 14, 2021
September 29, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in Ambulatory Blood Pressure
The ambulatory blood pressure will be collected for a 24-hour period using an automatic device (Dyna-MAPA, Cardios, Brazil). The device, duly calibrated, will be connected to a cuff, in the arm of preference, for the evaluation measurements. The device will be programmed to take measurements throughout the day at 15-minute intervals and during the night every 30 minutes (between 11:00 p.m. and 7:00 a.m.). All subjects will be given forms to record possible eventualities during the use of the device.
24 hours after the session
Secondary Outcomes (2)
Change of clinical blood pressure from pre to post session
Before, immediately after, 15 minutes and 30 minutes after the session.
Change in vascular function from pre to post session
Before, immediately after and 30 minutes after the session.
Study Arms (3)
Handgrip exercise (morning)
EXPERIMENTALThe handgrip exercise session will be executed with four series (two in each arm) of two minutes of isometric contraction at 30% of maximum voluntary contraction, with a one-minute interval between series in the morning.
Control
NO INTERVENTIONIn the control session, the participants will remain at rest for the same period of time as in the handgrip exercise protocol.
Handgrip exercise (afternoon)
EXPERIMENTALThe handgrip exercise session will be executed with four series (two in each arm) of two minutes of isometric contraction at 30% of maximum voluntary contraction, with a one-minute interval between series in the afternoon.
Interventions
The participants will be randomized into three sessions, handgrip exercise in the morning, handgrip exercise in the afternoon, and control performed in the morning to analyze the acute effects of handgrip exercise on blood pressure and vascular function at different times of the day. After the morning sessions, ambulatory blood pressure will also be measured for 24 hours.
Eligibility Criteria
You may qualify if:
- diagnosis of hypertension controlled by up to three antihypertensive medications;
- SBP levels ≤ 180 mmHg and/or DBP ≤110 mmHg;
- no serious heart disease;
- no upper limb musculoskeletal injury that prevents the handgrip.
You may not qualify if:
- diagnosis of other cardiovascular diseases or diabetes during the study;
- change the class and/or dose of antihypertensive medication during the study;
- worsening of the disease (BP \> 180 or use of four or more medications).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Universidade Federal de Santa Catarina
Florianópolis, Santa Catarina, 88040-900, Brazil
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Aline M. Gerage, Dr.
Universidade Federal de Santa Catarina
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- OTHER
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
April 14, 2021
First Posted
April 23, 2021
Study Start
June 1, 2021
Primary Completion
August 30, 2021
Study Completion
August 30, 2021
Last Updated
September 30, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share